Drug profile · INN
guanfacine
INTUNIV
guanfacine (INTUNIV) is a adrenergic receptor alpha-2 agonist. Associated with Lacuna Pharma Pty Ltd.
EMA: approved TGA: approved Cardiovascular system (C02) C02AC02
Patents linked 1
Pipeline programs 17
News articles 0
Drug details — guanfacine
- Class
- Cardiovascular system (C02)
- Route
- —
- Patents
- 1
- Programs
- 17
- Data quality
- 0.89
Quick answer
guanfacine (INTUNIV) is a adrenergic receptor alpha-2 agonist. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN guanfacine
Brand INTUNIV
Mechanism Adrenergic receptor alpha-2 agonist
Therapeutic class Cardiovascular system (C02)
ATC code C02AC02
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Adrenergic receptor alpha-2 agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is guanfacine?
guanfacine (INTUNIV) is a adrenergic receptor alpha-2 agonist. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for guanfacine?
INTUNIV is a marketed brand name for guanfacine. Check FDA Drugs@FDA for the current US label holder and prescribing information.